{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:21:45Z","timestamp":1790875305943,"version":"4.1.0"},"reference-count":19,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Vasculitic skin lesions have been reported in association with both SARS-CoV-2 infection and vaccination. Whether viral proteins persist in lesional vessels beyond the acute phase remains unclear. The aim of this study was to investigate the presence of SARS-CoV-2 spike protein in persistent or delayed-onset cutaneous vasculitis temporally associated with COVID-19 infection or vaccination. This retrospective case\u2013control study includes 9 patients with persistent or delayed-onset vasculitic skin lesions following COVID-19 infection (n=4) or mRNA vaccination (n=5). Skin biopsies were analysed using immunofluorescence for SARS-CoV-2 spike protein. Prepandemic leukocytoclastic vasculitis (n=3) and healthy postinfection\/postvaccination skin (n=3) served as controls. Spike protein was detected in vascular endothelial cells of all 9 patients with COVID-19- or vaccine-associated vasculitis. Staining was absent in all prepandemic vasculitis and healthy control samples. Histopathology showed typical features of leukocytoclastic vasculitis without evidence of viral cytopathic changes. We found that SARS-CoV-2 spike protein can persist in endothelial cells of vasculitic skin lesions weeks to months after COVID-19 infection or mRNA vaccination. These findings suggest that retained viral proteins may contribute to prolonged or delayed-onset vasculitic skin manifestations. Further studies are needed to clarify the mechanisms underlying spike persistence and its clinical significance.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0308","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:45:31Z","timestamp":1785224731000},"source":"Crossref","is-referenced-by-count":1,"title":["Persistent SARS-CoV-2 Spike Protein in Vasculitic Skin Lesions after Infection or mRNA Vaccination: A Retrospective Case control Immunofluorescence Study"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3104-8539","authenticated-orcid":false,"given":"Andrea","family":"Gawaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Fehrenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jule","family":"Riebelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Hagelauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Volc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Forchhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"163698","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n Casas C, Catal\u00e0 A, Carretero Hern\u00e1ndez G, Rodr\u00edguez-Jim\u00e9nez P, Fern\u00e1ndez-Nieto D, Rodr\u00edguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71\u201377.","DOI":"10.1111\/bjd.19163"},{"key":"163699","doi-asserted-by":"crossref","unstructured":"Catal\u00e0 A, Mu\u00f1oz-Santos C, Galv\u00e1n-Casas C, Roncero Riesco M, Revilla Nebreda D, Sol\u00e1-Truyols A, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol 2022; 186: 142\u2013152.","DOI":"10.1111\/bjd.20639"},{"key":"163700","doi-asserted-by":"crossref","unstructured":"Kofler L, Forchhammer S. Delayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273-a previously undescribed reaction pattern of COVID arm. Hautarzt 2022; 73: 488\u2013490.","DOI":"10.1007\/s00105-022-04986-7"},{"key":"163701","doi-asserted-by":"crossref","unstructured":"Llamas-Velasco M, Fraga J, Rodr\u00edguez-Villa Lario A, Catal\u00e1 A, P\u00e9rez-Gonz\u00e1lez YC, Galv\u00e1n C, et al. A series of 69 COVID-related dermatoses with biopsy, immunohistochemistry with anti-spike 3, in situ hybridization and PCR: a critical reappraisal of viral involvement in COVID-19 skin lesions. Actas Dermosifiliogr 2023; 114: 747\u2013754.","DOI":"10.1016\/j.ad.2023.05.024"},{"key":"163702","doi-asserted-by":"crossref","unstructured":"Gawaz A, Schindler M, Hagelauer E, Blanchard G, Riel S, Vollert A, et al. SARS-CoV-2-induced vasculitic skin lesions are associated with massive spike protein depositions in autophagosomes. J Invest Dermatol 2024; 144: 369\u2013377.","DOI":"10.1016\/j.jid.2023.07.018"},{"key":"163703","doi-asserted-by":"crossref","unstructured":"Almehdi AM, Khoder G, Alchakee AS, Alsayyid AT, Sarg NH, Soliman SSM. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection 2021; 49: 855\u2013876.","DOI":"10.1007\/s15010-021-01677-8"},{"key":"163704","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020; 383: 2603\u20132615.","DOI":"10.1056\/NEJMoa2034577"},{"key":"163705","doi-asserted-by":"crossref","unstructured":"Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 2020; 586: 567\u2013571.","DOI":"10.1038\/s41586-020-2622-0"},{"key":"163706","doi-asserted-by":"crossref","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384: 403\u2013416.","DOI":"10.1056\/NEJMoa2035389"},{"key":"163707","doi-asserted-by":"crossref","unstructured":"Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. N Engl J Med 2020; 383: 2439\u20132450.","DOI":"10.1056\/NEJMoa2027906"},{"key":"163708","doi-asserted-by":"crossref","unstructured":"Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2022; 36: 172\u2013180.","DOI":"10.1111\/jdv.17744"},{"key":"163709","doi-asserted-by":"crossref","unstructured":"Sano H, Kase M, Aoyama Y, Sano S. A case of persistent, confluent maculopapular erythema following a COVID-19 mRNA vaccination is possibly associated with the intralesional spike protein expressed by vascular endothelial cells and eccrine glands in the deep dermis. J Dermatol 2023; 50: 1208\u20131212.","DOI":"10.1111\/1346-8138.16816"},{"key":"163710","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by A Delphi consensus. 2021. [cited 2021 October 6]."},{"key":"163711","doi-asserted-by":"crossref","unstructured":"McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis 2021; 21: 313\u2013314.","DOI":"10.1016\/S1473-3099(20)30986-5"},{"key":"163712","doi-asserted-by":"crossref","unstructured":"Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology 2010; 56: 3\u201323.","DOI":"10.1111\/j.1365-2559.2009.03443.x"},{"key":"163713","doi-asserted-by":"crossref","unstructured":"Dittmayer C, Meinhardt J, Radbruch H, Radke J, Heppner BI, Heppner FL, et al. Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral. Lancet 2020; 396: e64\u2013e65.","DOI":"10.1016\/S0140-6736(20)32079-1"},{"key":"163714","doi-asserted-by":"crossref","unstructured":"Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al. Persistence of SARS-CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol 2021; 12: 746021.","DOI":"10.3389\/fimmu.2021.746021"},{"key":"163715","doi-asserted-by":"crossref","unstructured":"Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 2023; 76: e487\u2013e490..","DOI":"10.1093\/cid\/ciac722"},{"key":"163716","doi-asserted-by":"crossref","unstructured":"Rong Z, Mai H, Ebert G, Kapoor S, Puelles VG, Czogalla J, et al. Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19. Cell Host Microbe 2024; 32: 2112\u20132130.","DOI":"10.1016\/j.chom.2024.11.007"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46594\/54897","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46594\/54898","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46594\/54907","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46594\/54897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:45:34Z","timestamp":1785224734000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0308","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}